Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Toxicology and Applied Pharmacology
|
August 9, 2019
Assessing children's exposure to manganese in drinking water using a PBPK model
M Yoon, C Ring, C B Van Landingham, et al.
Toxicology and Applied Pharmacology
|
February 27, 2017
A tissue dose-based comparative exposure assessment of manganese using physiologically based pharmacokinetic modeling-The importance of homeostatic control for an essential metal
P Robinan Gentry, Cynthia Van Landingham, William G Fuller, et al.
Integrated Environmental Assessment and Management
|
January 8, 2026
Environmental risk assessment and testing of UVCBs through balanced consideration of whole substances and representative constituent data: a tripartite perspective
Sandrine Déglin, J Samuel Arey, Marc Fernandez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 27, 2023
Recycling Tenofovir in Second-line Antiretroviral Treatment With Dolutegravir: Outcomes and Viral Load Trajectories to 72 weeks
Claire M Keene, Tali Cassidy, Ying Zhao, et al.
Regulatory Toxicology and Pharmacology : RTP
|
January 15, 2020
21<sup>st</sup> Century Approaches for Evaluating Exposures, Biological Activity, and Risks of Complex Substances: Workshop highlights
Ursula G Sauer, Robert A Barter, Richard A Becker, et al.
Regulatory Toxicology and Pharmacology : RTP
|
December 22, 2015
Case studies putting the decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) into practice
Josje H E Arts, Muhammad-Adeel Irfan, Athena M Keene, et al.
Regulatory Toxicology and Pharmacology : RTP
|
March 31, 2015
A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping)
Josje H E Arts, Mackenzie Hadi, Muhammad-Adeel Irfan, et al.
The American Journal of Pathology
|
June 5, 2010
Suppressed accumulation of cerebral amyloid {beta} peptides in aged transgenic Alzheimer's disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrow
C Dirk Keene, Rubens C Chang, Americo H Lopez-Yglesias, et al.
The Lancet. HIV
|
October 24, 2025
Reducing HIV incidence and mortality: two sides of the same coin in the approach to ending AIDS
Joseph N Jarvis, Peter Ehrenkranz, David S Lawrence, et al.
AIDS (London, England)
|
May 11, 2021
Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen
Claire M Keene, Rulan Griesel, Ying Zhao, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Toxicology and Applied Pharmacology
|
August 9, 2019
Assessing children's exposure to manganese in drinking water using a PBPK model
M Yoon, C Ring, C B Van Landingham, et al.
Toxicology and Applied Pharmacology
|
February 27, 2017
A tissue dose-based comparative exposure assessment of manganese using physiologically based pharmacokinetic modeling-The importance of homeostatic control for an essential metal
P Robinan Gentry, Cynthia Van Landingham, William G Fuller, et al.
Integrated Environmental Assessment and Management
|
January 8, 2026
Environmental risk assessment and testing of UVCBs through balanced consideration of whole substances and representative constituent data: a tripartite perspective
Sandrine Déglin, J Samuel Arey, Marc Fernandez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 27, 2023
Recycling Tenofovir in Second-line Antiretroviral Treatment With Dolutegravir: Outcomes and Viral Load Trajectories to 72 weeks
Claire M Keene, Tali Cassidy, Ying Zhao, et al.
Regulatory Toxicology and Pharmacology : RTP
|
January 15, 2020
21<sup>st</sup> Century Approaches for Evaluating Exposures, Biological Activity, and Risks of Complex Substances: Workshop highlights
Ursula G Sauer, Robert A Barter, Richard A Becker, et al.
Regulatory Toxicology and Pharmacology : RTP
|
December 22, 2015
Case studies putting the decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) into practice
Josje H E Arts, Muhammad-Adeel Irfan, Athena M Keene, et al.
Regulatory Toxicology and Pharmacology : RTP
|
March 31, 2015
A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping)
Josje H E Arts, Mackenzie Hadi, Muhammad-Adeel Irfan, et al.
The American Journal of Pathology
|
June 5, 2010
Suppressed accumulation of cerebral amyloid {beta} peptides in aged transgenic Alzheimer's disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrow
C Dirk Keene, Rubens C Chang, Americo H Lopez-Yglesias, et al.
The Lancet. HIV
|
October 24, 2025
Reducing HIV incidence and mortality: two sides of the same coin in the approach to ending AIDS
Joseph N Jarvis, Peter Ehrenkranz, David S Lawrence, et al.
AIDS (London, England)
|
May 11, 2021
Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen
Claire M Keene, Rulan Griesel, Ying Zhao, et al.
Page
of 8